Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_assertion type Assertion NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_head.
- NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_assertion wasGeneratedBy ECO_0000203 NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_provenance.
- NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_assertion wasDerivedFrom befree-20150227 NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_provenance.
- NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_assertion SIO_000772 21083499 NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_provenance.
- NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_assertion evidence source_evidence_literature NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_provenance.
- NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_assertion description "[The primary objective of this first multicenter, prospective, single-blind, dose escalation study was to obtain safety and tolerability information of the iNOS lipoplex (CAR-MP583) gene therapy for reducing restenosis following PCI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593852.RAxE9TbtwkGHgfc0yA-1INXsSVwhp1rFbDt9HFfl0ABXw130_provenance.